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osting by EAbstract Introduction: Spasticity can be deﬁned as a velocity-dependent resistance to passive
movement of a joint and its associated musculature. Functional neurosurgery should be considered
when spasticity cannot be controlled by physical therapy and medications.
Objective: This study was done to evaluate the functional results of microsurgical DREZotomy
(MDT) in a consecutive series of 15 paraplegic patients suffered from generalized spasticity of lower
limbs.
Methods: This retrospective study included 15 paraplegic patients (10 due to spinal cord injury and
5 due to disseminated sclerosis) who underwent MDT for treatment of spasticity. The male to
female ratio was 2–1 (10 males and 5 females) and their ages ranged from 22 to 56 years with mean
age of 39 years. Assessment of spasticity was done using modiﬁed Ashworth scale and global func-
tional score. All cases underwent MDT that consisted of a longitudinal incision of the dorsolateral
sulcus, performed ventrolaterally at the entrance of the rootlets into the sulcus, followed by bipolar
coagulations performed inside the sulcus, down to the apex of the dorsal horn, continuously along
all the spinal cord segments selected for surgery. Mean postoperative follow up examination period
was 30 months..com
ersity Faculty of Medicine.
. All rights reserved.
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158 W. FouadResults: There was no operative mortality. Postoperatively, all the patients had improvement of
their spasticity grade. Assessment of outcome after surgery was done by comparing global func-
tional score for spastic paraplegic patients before and after surgery. At the last follow up examina-
tion period, excellent results were obtained in 33.3% of patients, good results in 60% of patients,
and fair results in 6.7% of patients.
Conclusion: MDT typically had a dramatic effect on tone in lower limbs. Better long-term results
were obtained in the spastic patients caused by spinal cord injury (excellent results in 40%) than in
the spasticity caused by disseminated sclerosis (excellent results in 20%).
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reserved.Figure 1 Schematic representation of organization of ﬁbers at
DREZ area and target of MDT.2 DH= dorsal horn, TL = tract
of Lissauer myot = myotatic ﬁbers, DC = dorsal column.
PR = pial ring. MDT (arrowhead) cuts most of the ﬁne ﬁbers
and myotatic ﬁbers and enters the medial (excitatory) portion of
TL and the apex of the dorsal horn.1. Introduction
Spasticity can be deﬁned as a velocity-dependent resistance to
passive movement of a joint and its associated musculature.1
Spasticity is characterized by hyperexcitability of the stretch-
reﬂex related to the loss of inhibitory inﬂuences from descend-
ing supraspinal structures.2 Spasticity should not be treated
just because it is present as it may be useful for compensating
for loss of motor power.3 Spasticity should be treated only
when excess tone leads to further functional losses, impairs
locomotion or induces deformities.4 Functional neurosurgery
should be considered when hyperspasticity cannot be con-
trolled by physical therapy and medications.5,6
The methods of surgical management are classiﬁed accord-
ing to whether their impact is general or focal and whether the
effects are temporary or permanent.1 They include not only
intrathecal baclofen therapy (ITB) and botulinum toxin injec-
tions, but also destructive surgery directed to the peripheral
nerves, dorsal roots, dorsal root entry zone or spinal cord.7,8
When harmful spasticity affects the whole limb in paraple-
gic patients, surgery involving the dorsal roots as dorsal
rhizotomies or dorsal root entry zone as microsurgical DREZ-
otomy (MDT) may be the solution.9 MDT attempts to selec-
tively interrupt the small nociceptive ﬁbers (situated laterally
and centrally respectively), while sparing the large leminiscal ﬁ-
bers, which are regrouped medially (Fig. 1).2 Complementary
orthopedic operations are frequently needed in patients with
associated irreducible contractures, tendon retractions, and/
or joint deformities.10
1.1. Objective
This study was done to evaluate the functional results of MDT
in a consecutive series of 15 paraplegic patients suffered from
generalized spasticity of lower limbs and to compare these re-
sults with the results of the other authors reported in the
literature.
2. Methods
This retrospective study included 15 paraplegic patients [10
due to spinal cord injury (SCI) and 5 due to disseminated scle-
rosis (DS)] who underwent MDT for treatment of spasticity.
This study was done in Alexandria hospitals over a period of
5 years starting from January 2004 to December 2008. The
male to female ratio was 2–1 (10 males and 5 females) and their
ages ranged from 22 to 56 years with mean age of 39 years.
Craniospinal MRI was done for all cases of disseminated scle-
rosis. Spinal MRI was not done in the two patients with lower
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of plate and screws ﬁxation. Preoperative urodynamic studies
and cystomyography were done for all patients.
Selection and assessment of patients were performed care-
fully. Once the spastic state had been demonstrated as harm-
ful, one has to determine the respective involvement in the
abnormal posture of spasticity (treated with MDT) and only
articular, muscular, tendinous, and/or ligamentous limitations
(relieved by orthopedic procedures). If doubt persists after de-
tailed clinical examination, a testing of passive articular mobil-
ity should be performed under anesthesia. When spasticity
plays the larger role in the articular limitations, abnormal pos-
tures were signiﬁcantly diminished during the test. If this was
not the case, orthopedic surgery may be the initial or the only
treatment. Nerve blocks with xyloacaine may also be used for
testing.
Preoperative assessment of the patients by measuring the
grade of spasticity was done using both modiﬁed Ashworth
scale (Table 1) and global functional score that measured the
degree of disability related to spasticity (Table 2).
2.1. Surgical technique
Surgery was performed under general anesthesia, with an ini-
tial short lasting curarization to allow intraoperative observa-
tion of motor responses to electrical stimulation of the nerve
roots. A laminectomy was performed from T10 to L2. The
dura and arachnoid were opened longitudinally, and the ﬁlum
terminale was isolated. Identiﬁcation of roots was performed
by electrical stimulation. MDT consisted of a longitudinal inci-
sion of the dorsolateral sulcus, performed ventrolaterally at the
entrance of the rootlets into the sulcus, and of microbipolar
coagulations, performed inside the sulcus, down to the apex
of the dorsal horn, continuously along all the spinal cord seg-
ments selected for surgery (Fig. 2).
3. Results
MDT was performed on both sides from L1 to S1 in eight
cases, from L2 to S1 in four cases and from L2 to S4 in two
cases who had spastic bladder as revealed by preoperative uro-
dynamic studies and cystomyography that showed decreased
bladder capacity and accelerated uninhibited contraction.
MDT was done on the right side only in one case from L2
to S1.
All patients were followed up after surgery, at the discharge
from the hospital then at 3 months postoperatively. The meanTable 1 Modiﬁed Ashworth scale.
Grade Patient’s status
0 No increase in muscle tone
1 Slight increase in tone with a catch and release or minimal
resistance at end of range of motion
1+ Slight increase in tone but with minimal resistance through
range of motion following catch
2 More marked increase in tone but limb easily moved
3 Considerable increase in tone, passive movement is diﬃcult
4 Aﬀected part is rigidpostoperative follow-up period was 2.5 years (range,
1–5 years).
There was no perioperative mortality. As regards the mor-
bidity, three patients had post-operative CSF leak. Two
patients had wound infection. One further patient had bacter-
emia due to urinary tract infection, which was treated with sys-
temic antibiotics.
Assessment of outcome after surgery was done by compar-
ing global functional score for spastic paraplegic patients be-
fore and after surgery (with a total of 20/20 denoting a
bedridden and totally dependent patient). Improvement of
more than 10 points was considered excellent, between 5 and
10 points was considered good and less than 5 points was con-
sidered fair results. At the last follow up period, excellent re-
sults were obtained in 33.3% of patients, good results in
60% of patients, and fair results in 6.7% of patients. In all pa-
tients with excellent or good results, the reduction of spasticity
was accompanied by complete withdrawal of medications.
In this study all patients preoperatively had spasticity either
G3 or G4 as measured by modiﬁed Ashworth scale, that im-
proved postoperatively by a least three grades in all of them.
Better long-term results were obtained in the spastic pa-
tients caused by SCI (excellent results were obtained in 40%
of cases) than in the spasticity caused by DS (excellent results
were obtained in 20% of cases).
In this study the two patients with spastic bladder were im-
proved after surgery as marked both clinically by stoppage of
urine leakage around the catheter and by postoperative urody-
namic studies and cystomyography.
Summary data and outcome of these 15 patients are listed
in Table 3.
4. Discussion
Spasticity is a motor disorder characterized by an increase in
tonic stretch reﬂexes with exaggerated tendon jerks, resulting
from hyper excitability of the stretch reﬂex, as one of the com-
ponents of upper motor neuron (UMN) syndrome.11 The clin-
ical features of UMN syndrome can be divided into two main
groups which are positive phenomenon (spasticity, clonus,
rigidity) and negative phenomenon (weakness, incoordination,
loss of dexterity).12 UMN modulates important segmental mo-
tor reﬂex activity in the spinal cord. The majority of positive
phenomenons of the UMN syndrome may arise due to inter-
ruption of the supraspinal control of these spinal reﬂexes.13
Pathophysiology of spasticity and UMN syndrome continues
to be a complex and an incompletely understood area.14
Generally patients do not complain about spasticity; they
are more likely to be aware of stiffness, deformity and limita-
tions in functional abilities.15 After a period of time, the pa-
tients will have a mixture of spasticity and muscle shortening
or contracture. There are two types of deformities, dynamic
caused by spasticity and ﬁxed described as contracture that re-
mains present under local blocks or anesthesia. The differenti-
ation between dynamic from ﬁxed deformities is of prime
importance before deciding any surgical treatment. The dy-
namic range of motion measures are useful starting points,
supplemented with instrumental measures of spasticity and
its effects on function, such as motion.16 Spasticity should
not be treated just because it is present; it should be treated be-
cause it is harmful. Patients may use spasticity in functional
Table 2 Global functional score for paraplegic patients with spasticity in the lower limbs.
Component Score
Pain
Absent 0
Mild and rare; no inﬂuence on daily life 1
Mild, but frequent; inducing depression 2
Marked and frequent; participating to the disability 3
permanent and severe; inducing suicide desire 4
Spasms
Absent 0
Mild and rare spasm, only during mobilization; no disability 1
Mild but frequent spasms during mobilization; moderate disability 2
Marked and frequent, spontaneous spasms; making sitting position uncomfortable 3
Almost constant severe spasms; making sitting position impossible 4
Sitting position
Normal and comfortable 0
Normal posture, but slightly uncomfortable 1
Marked diﬃculty, causing reduction of sitting periods 2
Severe diﬃculty; patients to be tied down in position 3
Impossible 4
Body transfers
Normal 0
Mild diﬃculty 1
Moderate diﬃculty; can do but only from bed to chair 2
Marked diﬃculty; need for a person helping 3
Severe diﬃculty; need for two persons helping 4
Washing and dressing
Normal 0
Mild diﬃculty 1
Moderate diﬃculty; can do but slowly 2
Marked diﬃculty; need for a person helping 3
Severe diﬃculty; totally dependant 4
160 W. Fouadactivities. Spasticity should only be treated when excess muscu-
lar tone leads to further functional losses, impairs locomotion,
or induces deformities, or chronic pain.17 So in patients with
no residual motor function, the objectives of the treatment
are improvement in function, prevention of deformities, or
alleviation of discomfort and pain. This should be explained
carefully to patients what can be gained and what will not be
obtained by surgery.18
In this study, the most common cause of spastic paraplegia
was SCI (spasticity of spinal origin) that was found in 10 pa-
tients, of these ﬁve patients had previous traumatic cord con-
tusion at lower cervical level, while the other ﬁve patients
had previous dorsal cord injury (1 upper dorsal, 2 middorsal
and 2 at lower dorsal), Only the two patients with lower dorsal
spine injury had previous operation in the form of plate and
screw ﬁxation due to fracture of dorsal 12 vertebra. The second
common cause was DS that was found in ﬁve cases (spasticity
of both cerebral and spinal origin). Other causes of spastic
paraplegia of cerebral origin include cerebral palsy, cerebro-
vascular stroke and traumatic brain injury which were not in-
cluded in this study.19
In this study, the male to female ratio was 2–1 (10 males
and 5 females) and their ages ranged from 22 to 56 years with
mean age of 39 years. This could be explained by the fact that
SCI that constitute the majority of this series was more com-
mon in young males (males constitute 80% of cases of SCI
and their mean age was 34 years).For measuring the spasticity, Ashworth developed a stan-
dardized scale to document resistance to passive movements.20
It is a simple, easy to use test. The scale has been shown to cor-
relate with other more reliable measures such as electromyog-
raphy measurements. The disadvantage of this scale is the fact
that it measured the combined effect of both biochemical and
neural components of tone also the lake of standardization
technique in performing the tone measurements. Repetitive
movement of the limb may modify stretch reﬂex and inﬂuence
more dynamic biochemical properties of the muscle. The force
applied in moving the limb should also be standardized.21
Preoperative assessment of the patients by measuring the
degree of disability related to their spasticity was done using
global functional score for paraplegic patients with spasticity
in lower limbs. This score developed by Millet and associate
quantiﬁes ﬁve components that are directly inﬂuenced by spas-
ticity, abnormal postures, and articular limitations and are
part of the patient’s everyday life (Table 2).22 The score goes
from 0 to 4 for each component, with a total of 20/20 denoting
a bed ridden and totally dependent patient. A score of 10/20
was seen to correspond reproducibly to the threshold between
a minimally acceptable and an unacceptable condition and
thus was identiﬁed as the lowest position at which to consider
surgery. The score was also used for the assessment of outcome
after surgery by comparing the score before and after surgery.
All patients in this study had preoperative scores more than
10/20.
Table 3 Summary data and outcome of 15 paraplegic patients who underwent MDT.
No Age Sex Etiology Spasticity grade
Ashworth scale
Level of DREZ
lesion
Complications Outcome using globa functional score
Right
side
Left
side
Preop. Postop.
1 year
Pre-
operative
score
Score t
3 mo s
posto ratively
Score at last
follow up
postoperative period
in months (m)
1 32 M Cervical
SCI
G 3 G 1 L1–S1 L1–S1 12 5 Go result 4 Good result 36 m
2 41 M D.S. G 4 G 0 L1–S1 L1–S1 CSF leak 16 5 Exc lent result 4 Excellent result 48 m
3 25 M Dorsal
SCI
G 3 G 1 L2–S1 L2–S1 13 4 Go result 4 Good result 60 m
4 45 M D.S G 3 G 1 L1–S1 L1–S1 13 6 Go result 6 Good result 30 m
5 39 M Cervical
SCI
G 3 G 0 L2–S1 L2–S1 15 4 Exc lent result 4 Excellent result 34 m
6 29 M Dorsal
SCI
G 4 G 1+ L1–S1 L1–S1 CSF leak 17 6 Exc lent result 9 Good result 34 m
7 51 F D.S. G 3 G 1 L2–S1 L2–S1 13 5 Go result 5 Good result 40 m
8 22 F Dorsal
SCI
G 3 G 1 L2–S1 Wound
infection
11 7 Fai esult 7 Fair result 31 m
9 31 M Cervical
SCI
G 3 G 1 L1–S1 L1–S1 14 3 Exc lent result 3 Excellent result 24 m
10 47 M Dorsal
SCI
G 3 G 1 L1–S1 L1–S1 16 5 Exc lent result 8 Good result 22 m
11 48 F D.S. G 4 G 1+ L1–S4 L1–S4 Wound
infection
18 7 Exc lent result 9 Good result 28 m
12 46 F Cervical
SCI
G 3 G 0 L1–S1 L1–S1 15 6 Go result 6 Good result 24 m
13 56 F D.S. G 3 G 0 L1–S1 L1–S1 CSF leak 12 5 Go result 5 Good result 12 m
14 36 M Cervical
SCI
G 3 G 1 L2–S1 L2–S1 14 3 Exc lent result 3 Excellent result 22 m
15 34 M Dorsal
SCI
G 4 G 1 L1–S4 L1–S4 Bacteremia
due to UTI
17 6 Exc lent result 6 Excellent result 15 m
SCI = spinal cord injury, D.S. = disseminated sclerosis. Preop. = preoperative, Postop. = postoperative.
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Figure 2 MDT operative technique at the lumbosacral level. (A)
The dorsal roots are retracted dorsomedially and held with a small
hook, to gain access to the dorsolateral sulcus. (B) Incision is
performed using a micro-knife, along the dorsolateral sulcus. (C)
Micro-coagulations inside the sulcus down to the apex of the
dorsal horn. (D) The lesion is completed and apex of dorsal horn
is exposed.
162 W. FouadMDT was indicated only when spasticity has resisted all
forms of physiotherapy and drug treatments.5 The microsurgi-
cal lesions were performed at the selected spinal segments that
correspond to the lower limb myotomes. It was performed on
both sides from L1 to S1 in eight cases, from L2 to S1 in four
cases and from L2 to S4 in two cases because there was a spas-
tic bladder. MDT was done on the right side only in one case
from L2 to S1 because he had ﬂexion deformity on the right
knee joint but the opposite side was controlled enough by
physiotherapy and antispasmodics. The longitudinal incision
was made with a microknife followed by bipolar coagulations
in dorsolateral sulcus. If the laxity of the root was sufﬁcient,
the incision was performed continuously, If not, a partial inci-
sion was made successively on each rootlet of the root, after
isolation of each one by separating the tiny arachnoid mem-
branes that hold them together.23
Intraoperative neurophysiologic monitoring was done by
observation of muscular responses to stimulation of the dorsal
roots from L1 to S1. Stimulation of the S2 to S4 dorsal roots
could be assessed by recording of the motor anal response by a
ﬁnger introduced into the anus.24
Some authors marked that intraoperative monitoring of
somatosensory evoked potentials (SEP) make localization of
dorsal root entry zone more accurate and minimize the possi-
bility of damage of adjacent long tracts.25,26 Also they found
that intraoperative neurophysiologic monitoring were time-
consuming, instead they measured 30 mm above the exit from
the conus of the tiny coccygeal root which was the landmark
between the S1 and S2 that could be sufﬁcient in the patientswho already have severe preoperative impairment of their
vesicoanal functions.27 In this study SEP were not performed,
only intraoperative electrical stimulation of the nerve roots
and observation of motor response in the speciﬁc muscle
groups innervated by this root was done.
In this study the mean operation time was 4.5 h and the
mean volume of blood loss was 850 ml. The excess blood loss
was due to rich vasculature of the conus. The dorsolateral
spinal artery courses along the dorsolateral sulcus. Its diameter
is 0.1–0.5 mm, and it is fed by the posterior radicular arteries
and joins caudally with the descending anterior branch of
the Adamkiewicz artery. The dorsolateral spinal artery had
to be preserved by being freed from the sulcus. MDT was dif-
ﬁcult especially in the two cases with previous injury at lower
dorsal region due to previous adhesion and scaring and necro-
tic cysts inside the cord. Similar to this study, Mertens et al.
had reported a mean operation time of 4 h and a mean volume
of blood loss of 650 ml.28
Like other series, there were no postoperative mortali-
ties.28,29 Two cases had superﬁcial wound infection. One of
them was treated successfully using the proper antibiotics after
performing culture and sensitivity from the wound. While the
second patient was diabetic and required a surgical debride-
ment with the antibiotics. Also three patients had CSF leak
that were treated with positioning and compression. Lastly
one further patient had bacteremia due to urinary tract infec-
tion that was treated with systemic antibiotics. Similarly Sin-
dou et al.30 who retrospectively reviewed 44 cases with MDT
in SCI reported two cases with wound infection treated and
cured with antibiotics and three patients had post-operative
CSF leak; of them, two were treated by positioning and com-
pression, while an operation was needed for dural repair in the
third patient. One patient had subcutaneous hematoma that
required surgical drainage. One further patient had bacteremia
due to urinary tract infection that was treated with systemic
antibiotics.
In this study the spasticity had improved in all cases post
operatively, as regards grade of spasticity measured by Ash-
worth scale and improvement in the functional score. All pa-
tients in this study had more comfort, less pain and ability
to resume physical therapy with more functional gain. The
muscular tone was diminished after MDT due to interruption
of the afferent component of the myotatic monosynaptic and
the nociceptive polysynaptic reﬂexes, which would deprive
the somatosensory relays of the dorsal horn from most of its
excitatory inputs.5
It is necessary to provide neurosurgical treatment together
with intensive physical therapy for several weeks. To take
the maximal beneﬁt out of surgery, patients have to optimize
their new neurological status by a rigorous and intensive pro-
gram of physical therapy. The result of surgery and its impact
on the daily life of patients can be appreciated only after a fol-
low-up of not less than 3 months.31 In this study, at 3 months
follow up period, excellent results were obtained in eight pa-
tients (53.3%), and good results in six patients (40%). At the
last follow up period (mean 2.5 years) excellent results had ob-
tained in only 33.3% of cases while good results in 60% of
cases. The decline of excellent results with time (from 53.3%
at 3 months follow up, to 33.3% at last follow up period)
might be due to secondary soft tissue changes like stiffness
of muscles and tendons presumably occurred as a result of
muscle not being placed through a normal range of move-
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spasticity due to SCI than in cases of spasticity due to DS
(60% versus 40% at 3 months follow up, 40% versus 20% at
last follow up period). This could be related to the origin of
spasticity, it had a spinal origin in cases of SCI but it had both
cerebral and spinal origin in cases of DS. These results were
nearly the same like other authors, but many authors did not
correlate their results to the cause or the origin of the spastic-
ity.5,19 In this study two cases with spastic bladder were im-
proved after surgery as marked both clinically by stoppage
of urine leakage around the catheter, electrophysiologically
and by using urodynamic studies, this might due to increase
in the bladder capacity because the detrusor muscle was not
irreversibly ﬁbrotic.33
Sindou et al.34 reviewed their series that consisted of 175
paraplegic patients who underwent MDT at the lumbosacral
level for excessive spasticity. MDT was performed bilaterally
from L2 to S2 in 158 cases and unilaterally in 17 cases. Also
it was performed from L2 to S4 in 15 cases with spastic
bladder. Mean follow-up was 9 years. They obtained a sig-
niﬁcant decrease in spasticity (at least a 2-point reduction
in Ashworth score) allowing the withdrawal of antispas-
modic medications in 75% of patients. Bladder capacity
was signiﬁcantly improved in 85%; in the patients who im-
proved. They reported better results of their cases caused by
pure spinal origin (80%) followed by disseminated sclerosis
(75%) and least improvement in spasticity caused by cere-
bral origin (60%). They concluded that reduction in spastic-
ity usually results in a signiﬁcant improvement of abnormal
postures and articular limitations that was achieved in 90%
of their patients.34
5. Conclusions
MDT typically has a dramatic effect on tone in lower limbs.
Surgical indications must be restricted to paraplegic patients
with severe disability who are unable to walk comfortably in
a wheelchair or are exposed to pressure sores in bed, especially
if additional pain from spasms, contractures, or neurotrophic
disturbances is present. MDT can be indicated to treat neuro-
genic bladders when there is no voluntary micturation and if
uninhibited detrusor contractions result in voiding around
the catheter or in between intermittent self-catheterization.
Better long-term results were obtained in the spasticity caused
by spinal cord injury (excellent results in 40%) than in the
spasticity caused by disseminated sclerosis (excellent results
in 20%).
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